SciCann Therapeutics receives notice of allowance for its enhanced CBD therapy US patent for NASH
October 02, 2019 13:06 ET
|
SciCann Therapeutics Inc.
TORONTO and TEL AVIV, Israel, Oct. 02, 2019 (GLOBE NEWSWIRE) -- SciCann Therapeutics is pleased to announce that it has received a notice of allowance from the United States Patent and Trademarks...
SciCann Therapeutics launch liver disease research program in Tel Aviv University
January 21, 2019 09:00 ET
|
SciCann Therapeutics Inc.
TORONTO and TEL AVIV, Israel, Jan. 21, 2019 (GLOBE NEWSWIRE) -- SciCann Therapeutics is pleased to announce that it has launched a novel sponsored research program in Tel Aviv University, focused on...
SciCann Therapeutics Announces Positive ISA Report for “Steady Stomach” CBD Combination Therapy Patent
November 06, 2018 08:00 ET
|
SciCann Therapeutics Inc.
TORONTO, Nov. 06, 2018 (GLOBE NEWSWIRE) -- SciCann Therapeutics Inc. (“SciCann”) announced today it has received a positive International Search Authority (ISA) report from the Patent Cooperation...
SciCann Therapeutics reports positive pre-clinical results for proprietary CBD combination product
August 23, 2018 07:30 ET
|
SciCann Therapeutics Inc.
TORONTO, Aug. 23, 2018 (GLOBE NEWSWIRE) -- SciCann Therapeutics Inc reports today positive results of a pre-clinical efficacy study with its proprietary “Steady Stomach” CBD combination product for...